Kymera Therapeutics Presents Positive Data Demonstrating Robust IRAK4 Degradation and…
Mean IRAK4 degradation of up to 96% in PBMC and up to 97% inhibition of ex vivo induction of multiple proinflammatory cytokines observed, suggesting potential for broad anti-inflammatory…